Differential cellular pattern of gene expression for two distinct cGMP-inhibited cyclic nucleotide phosphodiesterases in developing and mature rat brain

Neuroscience

Volumn 72, Issue 2, 1996, Pages 567-578

  Reinhardt, R R ^a,b   Bondy, C A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Brain insulin; cAMP; Enzyme; mRNA; Phosphodiesterase

Indexed keywords

CYCLIC AMP; CYCLIC GMP; ISOENZYME; MESSENGER RNA; PHOSPHODIESTERASE;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN REGION; CONTROLLED STUDY; EMBRYO; FETUS; GENE EXPRESSION; IN SITU HYBRIDIZATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; BRAIN; EPITHELIAL CELLS; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IN SITU HYBRIDIZATION; ISOENZYMES; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029876116     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00520-X     Document Type: Article

References (29)

1. Baroni M. D., Monti P. and Alberghina L. (1994) Repression of growth-regulated G1 cyclin expression by cyclic AMP in budding yeast. Nature 371, 339-345.
2. Beebe S. J., Redmon J. B., Blackmore P. F. and Corbin J. D. (1985) Discriminative insulin antagonism of stimulatory effects of various cAMP analogs on adipocyte lipolysis and hepatocyte glycogenolysis. J. biol. Chem. 260, 15781-15788.
3. Bentley J. K. and Beavo J. A. (1992) Regulation and function of cyclic nucleotides. Curr. Opin. Cell Biol. 4, 233-240.
4. Bondy C. A. (1991) Transient IGF-I gene expression during the maturation of functionally-related central projection neurons. J. Neurosci. 11, 3442-3455.
5. Bondy C., Werner H., Roberts C. T. Jr and LeRoith D. (1992) Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience 46, 909-923.
6. Bondy C. A., Zhou J. and Lee W. H. (1993) In situ hybridization histochemistry. In Handbook of Endocrine Research Techniques (eds de Pablo F. and Scanes C. G.), pp. 266-288. Academic Press, New York.
7. Colucci W. (1993) Search for effective and safe orally active positive inotropic drugs for the treatment of heart failure. Cardiol. Rev. 1, 42-49.
8. Conti M., Jin S. L. C., Monaco L., Repaske D. R. and Swinnen J. V. (1991) Hormonal regulation of cyclic nucleotide phosphodiesterases. Endocrin. Rev. 12, 218-234.
9. Harrison S. A., Reifsnyder D. H., Gallis B., Cadd G. G. and Beavo J. A. (1986) Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterases: a receptor for new cardiotonic drugs. Molec. Pharmac. 29, 506-514.
10. Hayes T. E., Valtz N. L. M. and McKay R. D. G. (1991) Downregulation of CDC2 upon terminal differentiation of neurons. New Biol. 3, 259-269.
11. Krupinski J. (1991) The adenylyl cyclase family. Molec. Cell Biochem. 104, 73-79.
12. Manganiello V. C., Smith C. J., Degerman E. and Belfrage P. (1990) Cyclic GMP-inhibited cyclic nucleotide phosphodiesterases. In Cyclic Nucleotide Phosphodiesterases: Structure, Regulation, and Drug Action (eds Beavo J. A. and Houslay M. D.), pp. 87-117. Wiley, Chichester.
13. Manganiello V. C., Smith C. J., Degerman E., Vasta V., Tornqvist H. and Belfrage P. (1991) Molecular mechanisms involved in the antilipolitic action of insulin: phosphorylation and activation of a particulate cAMP phosphodiesterase. Adv. exp. Med. Biol. 293, 239-248.
14. Marcoz P., Prigent, A. F., Lagarde M. and Nemoz G. (1993) Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Molec. Pharmac. 44, 1027-1035
15. Matsuoka I., Giuili G., Poyard M., Stengel D., Parma J., Guellaen G. and Hanoune J. (1992) Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution. J. Neurosci. 12, 3350-3360.
16. Meacci E., Taira M., Moos J. M., Smith C. J., Movsesian M. A., Degerman E., Belfrage P. and Manganiello V. C. (1992) Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase. Proc. natn. Acad. Sci. U.S.A. 89, 3721-3725.
17. Moncada S., Palmer R. and Higgs E. (1991) Nitric oxide - physiology, pathophysiology, and pharmacology. Pharmac. Rev. 43, 109-142.
18. Mukai J., Asai T., Naka M. and Tanaka T. (1994) Separation and characterization of a novel isoenzyme of cyclic nucleotide phosphodiesterase from rat cerebrum. Br. J. Pharmac. 11, 389-390.
19. Nairn A. C., Hemmings H. C. and Greengard P. (1985) Protein kinases in the brain,. A. Rev. Biochem. 54, 931-976.
20. Reinhardt R. R., Chin E., Zhou J., Taira M., Murata T., Manganiello V. C. and Bondy C. A. (1995) Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases. J. clin. Invest. 95, 1528-1538.
21. Repaske D. R., Corbin J. G., Conti M. and Goy M. F. (1993) A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain. Neuroscience 56, 673-686.
22. Sadler S. E. (1991) Type III phosphodiesterase plays a necessary role in the growth-promoting actions of insulin, insulin-like growth factor-I, and Ha p21ras in Xenopus laevis oocytes. Molec. Endocrin. 5, 1939-1946.
23. Silver P. B., Lepore, R. E., O'Connor B., Lemp B., Hamel L. T., Bentley R. G. and Harris A. L. (1988) Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone. J. Pharmac. exp. Ther. 247, 34-42.
24. Simpson A. W. M., Reeves M. L. and Rink T. J. (1988) Effects of SKL and F94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets. Biochem. Pharmac. 37, 2315-2320.
25. Sonnenburg W. K. and Beavo J. A. (1994) Cyclic GMP and regulation of cyclic nucleotide hydrolysis. Adv. Pharmac. 26, 87-114.
26. Taira M., Hockman S., Calvo J. C., Belfrage P. and Manganiello V. C. (1993) Molecular cloning of the adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase. J. biol. Chem. 268, 18573-18579.
27. Vincent S. R. and Kimura H. (1992) Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46, 755-784.
28. Wood P. L. (1991) Pharmacology of the second messenger, cyclic guanosine 3′,5′-monophosphate, in the cerebellum. Pharmac. Rev. 43, 1-25.
29. Yan C., Bentley J. K., Sonnenburg W. K. and Beavo J. A. (1994) Differential expression of the 61 kDa and 63 kDa calmodulin-dependent phosphodiesterases in the mouse brain. J. Neurosci. 14, 973-984.